| Line 10: |
Line 10: |
| | * Quantification of Hgb mass loss vs. qBL in C-section. | | * Quantification of Hgb mass loss vs. qBL in C-section. |
| | | | |
| − | ==Not Super Exciting== | + | ==Very Ambitious, But Still Cool== |
| − | * Which findings on the preop note predict pressors use during the case? | + | * NIBP monitoring from head/neck |
| − | * EPIC timeline builder | + | * Better way of determining fluid status |
| − | * Ultrasound vs blind A-line first attempt success rate and complications? | + | * Novel reversal agents (e.g. volatile anesthetics, propofol, precedex) |
| | + | * Reversible chemical/optical/electromagnetic knockdown/inhibition/interference of pain nuclei/DRG/dorsal column/STT activity in rodents/primates |
| | | | |
| | ==Already Done== | | ==Already Done== |
| Line 20: |
Line 21: |
| | * Does precedex really delay emergence? ([https://journals.lww.com/anesthesia-analgesia/fulltext/2022/06000/the_effect_of_dexmedetomidine_on_postanesthesia.17.aspx 2022 Anesthesia and Analgesia Systematic Review and Meta-Analysis] says "NO"). | | * Does precedex really delay emergence? ([https://journals.lww.com/anesthesia-analgesia/fulltext/2022/06000/the_effect_of_dexmedetomidine_on_postanesthesia.17.aspx 2022 Anesthesia and Analgesia Systematic Review and Meta-Analysis] says "NO"). |
| | | | |
| − | ==Very Ambitious, But Still Cool== | + | ==Not Super Exciting/Impactful== |
| − | * NIBP monitoring from head/neck | + | * Which findings on the preop note predict pressors use during the case? |
| − | * Better way of determining fluid status
| + | * EPIC timeline builder |
| − | * Novel reversal agents (e.g. volatile anesthetics, propofol, precedex) | + | * Ultrasound vs blind A-line first attempt success rate and complications? |
| − | * Reversible chemical/optical/electromagnetic knockdown/inhibition/interference of pain nuclei/DRG/dorsal column/STT activity in rodents/primates | |
| | | | |
| | =Resources= | | =Resources= |